Stay updated on Nivolumab Post Induction in NSCLC Clinical Trial
Sign up to get notified when there's something new on the Nivolumab Post Induction in NSCLC Clinical Trial page.

Latest updates to the Nivolumab Post Induction in NSCLC Clinical Trial page
- Check5 days agoChange DetectedThe page displays a new revision tag v3.6.2, indicating another revision of the study record. This change is metadata and does not modify the study content or its presentation.SummaryDifference0.1%

- Check12 days agoNo Change Detected
- Check19 days agoChange DetectedThe study record page now lists Ji-youn Han as a contact and shows a new 'Last verified' label, replacing the old verification wording, while a new revision (v3.6.0) is introduced and several guidance links such as 'How to Read a Study Record,' 'Common Questions,' and 'How to Join a Study' were added.SummaryDifference2%

- Check27 days agoChange DetectedThe page revision tag was updated from v3.5.4 to v3.5.5, indicating a minor update to the page's underlying version rather than to the study details.SummaryDifference0.1%

- Check48 days agoChange DetectedThe footer now shows Revision: v3.5.4, replacing the prior v3.5.3. This appears to be a small platform update and does not change the study details or navigation.SummaryDifference0.1%

- Check69 days agoChange DetectedThe page revision indicator was updated from v3.5.2 to v3.5.3, reflecting a website release without altering the study content.SummaryDifference0.1%

- Check76 days agoChange DetectedRevision updated from v3.5.0 to v3.5.2.SummaryDifference0.1%

Stay in the know with updates to Nivolumab Post Induction in NSCLC Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Nivolumab Post Induction in NSCLC Clinical Trial page.